94314-2
SARS-CoV-2 (COVID-19) RdRp gene [Presence] in Specimen by NAA with probe detection
Active
Term Description
Qualitative detection of nucleic acids within the RdRp gene of SARS coronavirus 2 (SARS-CoV-2) in various specimens, including lower & upper respiratory, serum, stool or urine, by nucleic acid amplification with probe-based detection. Various assays have been developed that contain primer-probe sets targeting RdRp gene. [https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance]
Source: Regenstrief LOINC
Part Description
LP417598-2 SARS coronavirus 2 RdRp gene
The Severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), first known as 2019 Novel Coronavirus (2019-nCoV), was first identified as the cause of a respiratory illness outbreak, later defined as Coronavirus Disease 2019 (COVID-19), in Wuhan, China. The full genome of the SARS-CoV-2 that causes COVID-19 was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Real time Reverse Transcription-Polymerase Chain Reaction (rRT-PCR) tests targeting regions within genes, including RdRp, S, N, M, and E genes, specific to SARS-CoV-2 have been developed by the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) and others for the diagnosis of COVID-19. Some assays only detect SARS-CoV-2 and other assays detect other strains (e.g. SARS-CoV) that are genetically similar.[CDC: coronavirus/2019-ncov][https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance]
Source: Regenstrief LOINC
Reference Information
Type | Source | Reference |
---|---|---|
Webcontent | Lab Tests Online®Copyright Copyright © 2021 Lab Tests Online. All rights reserved. | Coronavirus (COVID-19) Testing |
Package Insert | World Health Organization (WHO)Copyright Copyright © 2001 World Health Organization. | Diagnostic detection of 2019-nCoV by real-time RT-PCR |
Fully-Specified Name
- Component
- SARS coronavirus 2 RdRp gene
- Property
- PrThr
- Time
- Pt
- System
- XXX
- Scale
- Ord
- Method
- Probe.amp.tar
Additional Names
- Short Name
- SARS-CoV-2 RdRp Spec Ql NAA+probe
- Display Name
- SARS-CoV-2 (COVID-19) RdRp gene NAA+probe Ql (Specimen)
- Consumer Name Alpha Get Info
- SARS-CoV-2 (COVID-19) RdRp gene, Specimen
Ask at Order Entry
81959-9 Public health laboratory ask at order entry panel
This panel contains a convenience grouping of terms for questions commonly asked when an order is placed in a public health laboratory.
LOINC | Name | R/O/C | Cardinality | Example UCUM Units |
---|---|---|---|---|
81959-9 | Public health laboratory ask at order entry panel | |||
Indent81744-5 | Submitter's laboratory test method [Type] in Specimen | |||
Indent81658-7 | Suspected organism [Identifier] in Specimen | |||
Indent86952-9 | Preliminary testing done Specimen | |||
Indent86953-7 | Preliminary testing result Specimen | |||
Indent86955-2 | Preliminary testing affected submission for further testing Specimen | |||
Indent95417-2 | Whether this is the patient's first test for condition of interest | |||
Indent95418-0 | Whether patient is employed in a healthcare setting | |||
Indent95419-8 | Whether the patient has symptoms related to condition of interest | |||
Indent11368-8 | Illness or injury onset date and time | C | ||
Indent77974-4 | Whether the patient was hospitalized for condition of interest | |||
Indent95420-6 | Whether the patient was admitted to intensive care unit (ICU) for condition of interest | |||
Indent95421-4 | Whether patient resides in a congregate care setting | |||
Indent82810-3 | Pregnancy status | C | ||
Indent30525-0 | Age | a |
Example Answer List: LL744-4
Source: Regenstrief InstituteAnswer | Code | Score | Answer ID |
---|---|---|---|
Detected | LA11882-0 | ||
Not detected | LA11883-8 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.68
- Last Updated
- Version 2.69
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
94306-8 | SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG51017-8 | SARSCoV2 detection |
LG51019-4 | SARSCoV2 molecular detection |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-AT | German (Austria) | Synonyms: SARS-CoV-2 RdRP-Gen ql. /Material n. spez. PCR |
de-DE | German (Germany) | SARS-Coronavirus 2 RdRp-Gen: |
es-ES | Spanish (Spain) | Gen RdRp de SARS-CoV-2 (COVID-19): |
es-MX | Spanish (Mexico) | Gen RdRp del coronavirus 2 del SARS: |
fr-FR | French (France) | Coronavirus SARS-CoV-2 gène RdRp: |
fr-CA | French (Canada) | gène RdRp du coronavirus 2 du SRAS: Synonyms: #REF! |
it-IT | Italian (Italy) | SARS coronavirus 2, gene RdRp: Synonyms: Coronavirus della SARS Gene RdRp di SARS-CoV-2 (COVID-19) Microbiologia Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Sonda con amplificazione Sonda con amplificazione del target Sonda di DNA |
nl-NL | Dutch (Netherlands) | SARS-CoV-2 RdRp-gen: Synonyms: probe.amp.tar SARS-virus severe acute respiratory syndrome coronavirus 2; |
zh-CN | Chinese (China) | SARS 冠状病毒 2 RdRp 基因: Synonyms: 2019 新型冠状病毒; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=94314-2
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright